The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G
Open accessAbstract
As a primary target for opioid drugs and peptides, the mu opioid receptor (OPRM1) plays a key role in pain perception and addiction. Genetic variants of OPRM1 have been implicated in predisposition to drug addiction, in particular the single nucleotide polymorphism A118G, leading to an N40D substitution, with an allele frequency of 10-32%, and uncertain functions. We have measured allele-specific mRNA expression of OPRM1 in human autopsy brain tissues, using A118G as a marker. In 8 heterozygous samples measured, the A118 mRNA allele was 1.5-2.5-fold more abundant than the G118 allele. Transfection into Chinese hamster ovary cells of a cDNA representing only the coding region of OPRM1, carrying adenosine, guanosine, cytidine, and thymidine in position 118, resulted in 1.5-fold lower mRNA levels only for OPRM1-G118, and more than 10-fold lower OPRM1 protein levels, measured by Western blotting and receptor binding assay. After transfection and inhibition of transcription with actinomycin D, analysis of mRNA turnover failed to reveal differences in mRNA stability between A118 and G118 alleles, indicating a defect in transcription or mRNA maturation. These results indicate that OPRM1-G118 is a functional variant with deleterious effects on both mRNA and protein yield. Clarifying the functional relevance of polymorphisms associated with susceptibility to a complex disorder such as drug addiction provides a foundation for clinical association studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The A118G variant has enhanced binding and signaling properties, but low expression of mRNA (Zhang et al 2005; Kroslak et al 2007).”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Zhang et al 2005
Citations
Cites
Mfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404
Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry
Basbaum, A. I., & Fields, H. L. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001521 · Cited by 2,687
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214
Bond, C. E., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J. H., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,072
Duan, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg055 · Cited by 931
Evolutionary changes in cis and trans gene regulation
Wittkopp, P. J., Haerum, B. K., & Clark, A. G. (2004) · Nature · doi:10.1038/nature02698 · Cited by 873
Endogenous opioid systems and alcohol addiction
Herz, A. (1997) · Psychopharmacology · doi:10.1007/s002130050169 · Cited by 755
Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571
Allelic Variation in Gene Expression Is Common in the Human GenomePreprint
Lo, H. S., Wang, Z., Hu, Y., Yang, H. H., Gere, S., Buetow, K. H., & Lee, M. P. (2003) · Genome Research · doi:10.1101/gr.1006603 · Cited by 446
Bray, N. J., Buckland, P. R., Williams, N. M., Williams, H. J., Norton, N., Owen, M. J., & O’Donovan, M. C. (2003) · The American Journal of Human Genetics · doi:10.1086/376578 · Cited by 335
Research works printed but not linked: 1
- Kreek, 1996, Mol. Psychiatry, 1, 232
Cited by
Sorted by citations
Molecular mechanisms of opioid receptor-dependent signaling and behavior
Al-Hasani, R., & Bruchas, M. R. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318238bba6 · Cited by 1,067
Mu Opioids and Their Receptors: Evolution of a Concept
Pasternak, G. W., & Pan, Y. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007138 · Cited by 582
Anton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.2.135 · Cited by 451
Crews, K. R., Monte, A. A., Huddart, R., Caudle, K. E., Kharasch, E. D., Gaedigk, A., Dunnenberger, H. M., Leeder, J. S., Callaghan, J. T., Samer, C. F., et al. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2149 · Cited by 448
Zhang, Y., Bertolino, A., Fazio, L., Blasi, G., Rampino, A., Romano, R., Lee, M. T., Xiao, T., Papp, A. C., Wang, D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707106104 · Cited by 436
Self-citationThe comorbidity of insomnia, chronic pain, and depression: Dopamine as a putative mechanism
Finan, P. H., & Smith, M. T. (2012) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.03.003 · Cited by 380
Association of ABCB1/MDR1 and OPRM1 Gene Polymorphisms With Morphine Pain Relief
Campa, D., Gioia, A., Tomei, A., Poli, P., & Barale, R. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100385 · Cited by 344
Somogyi, A. A., Barratt, D. T., & Coller, J. K. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100095 · Cited by 327
Innate Immune Gene Polymorphisms in Tuberculosis
Azad, A. K., Sadée, W., & Schlesinger, L. S. (2012) · Infection and Immunity · doi:10.1128/iai.00443-12 · Cited by 313
Self-citationBurkett, J. P., & Young, L. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2794-x · Cited by 307
“The A118G variant has enhanced binding and signaling properties, but low expression of mRNA (Zhang et al. 2005; Kroslak et al. 2007).”
A genetic determinant of the striatal dopamine response to alcohol in men
Ramchandani, V. A., Umhau, J. C., Pavón, F. J., Ruiz-Velasco, V., Margas, W., Sun, H., Damadzic, R., Eskay, R. L., Schoor, M., Thorsell, A., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.56 · Cited by 298
The Interpersonal Dimension of Borderline Personality Disorder: Toward a Neuropeptide Model
Stanley, B., & Siever, L. J. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09050744 · Cited by 301
Genetics and the placebo effect: the placebome
Hall, K. T., Loscalzo, J., & Kaptchuk, T. J. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.009 · Cited by 281
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Johnson, B. A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.005 · Cited by 269
Way, B. M., Taylor, S. E., & Eisenberger, N. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812612106 · Cited by 264
The placebo effect: From concepts to genes
Colagiuri, B., Schenk, L. A., Keßler, M., Dorsey, S. G., & Colloca, L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.017 · Cited by 278
Ray, L. A., & Hutchison, K. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1069 · Cited by 258
Pharmacogenetic approaches to the treatment of alcohol addiction
Heilig, M. A., Goldman, D. A., Berrettini, W. H., & O’Brien, C. P. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3110 · Cited by 256
Stress, alcohol and drug interaction: an update of human research
Uhart, M., & Wand, G. S. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00131.x · Cited by 240
Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics
Kreek, M. J., Levran, O., Reed, B., Schlussman, S. D., Zhou, Y., & Butelman, E. R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60390 · Cited by 220
Kroslak, T., LaForge, K. S., Gianotti, R. J., Ho, A., Nielsen, D. A., & Kreek, M. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04738.x · Cited by 213
Gelernter, J. E., Gueorguieva, R. V., Kranzler, H. R., Zhang, H., Cramer, J. A., Rosenheck, R. A., Krystal, J. H., & the VA Cooperative Study #425 Study Group (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00339.x · Cited by 204
Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment
Walter, C., & Lötsch, J. (2009) · Pain · doi:10.1016/j.pain.2009.07.013 · Cited by 200
κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction
Butelman, E. R., Yuferov, V. P., & Kreek, M. J. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.05.005 · Cited by 194
Filbey, F. M., Ray, L. A., Smolen, A., Claus, E. D., Audette, A., & Hutchison, K. E. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00692.x · Cited by 195
Variation at the mu-opioid receptor gene ( OPRM1 ) influences attachment behavior in infant primates
Barr, C. S., Schwandt, M. L., Lindell, S. G., Higley, J. D., Maestripieri, D., Goldman, D., Suomi, S. J., & Heilig, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710225105 · Cited by 191
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches
Peciña, M., Karp, J. F., Mathew, S. J., Todtenkopf, M. S., Ehrich, E. W., & Zubieta, J.-K. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0117-2 · Cited by 197
Wildenberg, E. V. D., Wiers, R. W. H. J., Dessers, J., Janssen, R. G. J. H., Lambrichs, E., Smeets, H. J. M., & van Breukelen, G. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00258.x · Cited by 180
Opioid system and human emotions
Nummenmaa, L., & Tuominen, L. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13812 · Cited by 178
Arias, A. J., Feinn, R., & Kranzler, H. R. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.11.024 · Cited by 178
Expansion of the human μ-opioid receptor gene architecture: novel functional variants
Shabalina, S. A., Zaykin, D. V., Gris, P., Ogurtsov, A. Y., Gauthier, J., Shibata, K., Tchivileva, I. E., Belfer, I., Mishra, B. K., Kiselycznyk, C., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn439 · Cited by 174
Peciña, M., Love, T., Stohler, C. S., Goldman, D. A., & Zubieta, J.-K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.272 · Cited by 161
Janicki, P. K., Schuler, G. H., Francis, D., Bohr, A., Gordin, V., Jarzembowski, T. M., Ruiz-Velasco, V., & Mets, B. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000231634.20341.88 · Cited by 163
Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior
Mague, S. D., Isiegas, C., Huang, P., Liu‐Chen, L., Lerman, C. E., & Blendy, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901800106 · Cited by 160
Foulkes, T., & Wood, J. N. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000086 · Cited by 158
Zhang, H., Luο, X., Kranzler, H. R., Lappalainen, J., Yang, B., Krupitsky, E. M., Zvartau, E. E., & Gelernter, J. E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl024 · Cited by 153
Oertel, B. G., Schmidt, R., Schneider, A., Geißlinger, G., & Lötsch, J. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000220566.90466.a2 · Cited by 152
OPRM1 A118G Gene Variant and Postoperative Opioid Requirement
Hwang, I. C., Park, J. Y., Myung, S., Ahn, H. Y., Fukuda, K., & Liao, Q. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000405 · Cited by 152
Oertel, B. G., Kettner, M., Scholich, K., Renné, C., Roskam, B., Geißlinger, G., Schmidt, P. H., & Lötsch, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807030200 · Cited by 149
Moyer, R. A., Wang, D., Papp, A. C., Smith, R. M., Duque, L., Mash, D. C., & Sadée, W. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.208 · Cited by 151
Self-citationPharmacokinetics of Non-Intravenous Formulations of Fentanyl
Lötsch, J., Walter, C., Parnham, M. J., Oertel, B. G., & Geißlinger, G. (2012) · Clinical Pharmacokinetics · doi:10.1007/s40262-012-0016-7 · Cited by 144
The genetics of the opioid system and specific drug addictions
Levran, O., Yuferov, V. P., & Kreek, M. J. (2012) · Human Genetics · doi:10.1007/s00439-012-1172-4 · Cited by 147
Bertolino, A., Fazio, L., Caforio, G., Blasi, G., Rampino, A., Romano, R., Giorgio, A. D., Taurisano, P., Papp, A. C., Pinsonneault, J. K., et al. (2008) · Brain · doi:10.1093/brain/awn248 · Cited by 142
Self-citationHayashida, M., Nagashima, M., Satoh, Y., Katoh, R., Tagami, M., Ide, S., Kasai, S., Nishizawa, D., Ogai, Y., Hasegawa, J., et al. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.11.1605 · Cited by 141
Ray, R., Ruparel, K., Newberg, A. B., Wileyto, E. P., Loughead, J., Divgi, C. R., Blendy, J. A., Logan, J., Zubieta, J.-K., & Lerman, C. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018699108 · Cited by 138
OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models
Mague, S. D., & Blendy, J. A. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.12.016 · Cited by 138
Fukuda, K., Hayashida, M., Ide, S., Saita, N., Kokita, Y., Kasai, S., Nishizawa, D., Ogai, Y., Hasegawa, J., Nagashima, M., et al. (2009) · Pain · doi:10.1016/j.pain.2009.09.004 · Cited by 135
Tan, E.-C., Lim, E. C., Teo, Y.-Y., Lim, Y., Law, H.-Y., & Sia, A. T. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-32 · Cited by 133
Adult attachment style is associated with cerebral μ‐opioid receptor availability in humans
Nummenmaa, L., Manninen, S., Tuominen, L., Hirvonen, J., Kalliokoski, K. K., Nuutila, P., Jääskeläinen, I. P., Hari, R., Dunbar, R. I. M., & Sams, M. (2015) · Human Brain Mapping · doi:10.1002/hbm.22866 · Cited by 133
Current evidence for a genetic modulation of the response to analgesics
Lötsch, J., & Geißlinger, G. (2006) · Pain · doi:10.1016/j.pain.2006.01.010 · Cited by 132
A review of opioid addiction genetics
Crist, R. C., Reiner, B. C., & Berrettini, W. H. (2018) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2018.07.014 · Cited by 131
Differential Opioid Action on Sensory and Affective Cerebral Pain Processing
Oertel, B., Preibisch, C., Wallenhorst, T., Hummel, T. R., Geißlinger, G., Lanfermann, H., & Lötsch, J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100441 · Cited by 133
μ-Opioid Receptor Gene A118G Polymorphism Predicts Survival in Patients with Breast Cancer
Bortsov, A. V., Millikan, R. C., Belfer, I., Boortz-Marx, R. L., Arora, H., & McLean, S. A. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31824b96a1 · Cited by 129
Ray, L. A., MacKillop, J., & Monti, P. M. (2010) · Substance Use & Misuse · doi:10.3109/10826084.2010.482427 · Cited by 132
Genetic contributions to pain: a review of findings in humans
Fillingim, R. B., Wallace, M. R., Herbstman, D. M., Ribeiro-Dasilva, M., & Staud, R. M. (2008) · Oral Diseases · doi:10.1111/j.1601-0825.2008.01458.x · Cited by 134
Lötsch, J., von Hentig, N., Freynhagen, R., Grießinger, N., Zimmermann, M., Doehring, A., Rohrbacher, M., Sittl, R., & Geißlinger, G. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832b89da · Cited by 124
Genetic–epigenetic interaction modulates µ-opioid receptor regulation
Oertel, B. G., Doehring, A., Roskam, B., Kettner, M., Hackmann, N., Ferreirós, N., Schmidt, P. H., & Lötsch, J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds314 · Cited by 126
Association of OPRM1 A118G variant with the relative reinforcing value of nicotine
Ray, R., Jepson, C., Patterson, F., Strasser, A. A., Rukstalis, M. R., Perkins, K. A., Lynch, K. G., O’Malley, S. S., Berrettini, W. H., & Lerman, C. E. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0504-2 · Cited by 127
Ray, L. A., Miranda, R., Tidey, J. W., McGeary, J. E., MacKillop, J. M., Gwaltney, C. J., Rohsenow, D. J., Swift, R. M., & Monti, P. M. (2010) · Journal of Abnormal Psychology · doi:10.1037/a0017550 · Cited by 126
Searching for polymorphisms that affect gene expression and mRNA processing: Example ABCB1 (MDR1)
Wang, D., & Sadée, W. (2006) · The AAPS Journal · doi:10.1208/aapsj080361 · Cited by 120
Self-citationState-dependent μ-opioid modulation of social motivation
Løseth, G. E., Ellingsen, D., & Leknes, S. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00430 · Cited by 128
Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons
Lim, J.-E., Pinsonneault, J. K., Sadée, W., & Saffen, D. W. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001923 · Cited by 120
Self-citationInterindividual Variability of Methadone Response
Li, Y., Kantelip, J., Schieveen, P. G., & Davani, S. (2008) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256276 · Cited by 117
Schwantes-An, T.-H. L., Zhang, J., Chen, L., Hartz, S. M., Culverhouse, R., Chen, X., Coon, H. H., Frank, J., Kamens, H. M., Konte, B., et al. (2015) · Behavior Genetics · doi:10.1007/s10519-015-9737-3 · Cited by 120
Pinsonneault, J. K., Papp, A. C., & Sadée, W. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl192 · Cited by 114
Self-citationHuang, P., Chen, C., Mague, S. D., Blendy, J. A., & Liu‐Chen, L. (2011) · Biochemical Journal · doi:10.1042/bj20111050 · Cited by 117
Gong, L., Stamer, U. M., Tzvetkov, M. V., Altman, R. B., & Klein, T. E. (2014) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000057 · Cited by 113
Crist, R. C., & Berrettini, W. H. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.10.018 · Cited by 115
Drakenberg, K., Nikoshkov, A., Horváth, M., Fagergren, P., Gharibyan, A. L., Saarelainen, K., Rahman, S., Nylander, I., Bakalkin, G. Y., Rajs, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600871103 · Cited by 111
Schacht, J. P., Randall, P. K., Latham, P. K., Voronin, K. E., Book, S. W., Myrick, H., & Anton, R. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.74 · Cited by 108
Wang, D., Papp, A. C., Binkley, P. F., Johnson, J. A., & Sadée, W. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000230119.34205.8a · Cited by 108
Self-citationLu, P. L. (2015) · Pain Physician · doi:10.36076/ppj/2015.18.131 · Cited by 106
Barr, C. S., Schwandt, M., Lindell, S. G., Chen, S. A., Goldman, D., Suomi, S. J., Higley, J. D., & Heilig, M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.369 · Cited by 105
Yuferov, V. P., Levran, O., Proudnikov, D., Nielsen, D. A., & Kreek, M. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05275.x · Cited by 106
Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?
Mura, E., Govoni, S. M., Racchi, M., Carossa, Ranzani, G. N., Allegri, M., & van Schaik, A. (2013) · Journal of Pain Research · doi:10.2147/jpr.s42040 · Cited by 105
Johnson, A. D., Zhang, Y., Papp, A. C., Pinsonneault, J. K., Lim, J.-E., Saffen, D. W., Zunyan Dai, Y., Wang, D., & Sadée, W. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283050107 · Cited by 105
Self-citationGenetic modulation of the pharmacological treatment of pain
Lötsch, J., Geißlinger, G., & Tegeder, I. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.010 · Cited by 106
Deb, I., Chakraborty, J., Gangopadhyay, P. K., Choudhury, S. R., & Das, S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06472.x · Cited by 105
Fujita, K., Ando, Y., Yamamoto, W., Miya, T., Endo, H., Sunakawa, Y., Araki, K., Kodama, K., Nagashima, F., Ichikawa, W., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1029-2 · Cited by 104
Olsen, M. B., Jacobsen, L. M., Schistad, E. I., Pedersen, L. M., Rygh, L. J., Røe, C., & Gjerstad, J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1742-12.2012 · Cited by 103
Alcohol Use Disorder: Neurobiology and Therapeutics
Yang, W., Singla, R., Maheshwari, O., Fontaine, C. J., & Gil‐Mohapel, J. (2022) · Biomedicines · doi:10.3390/biomedicines10051192 · Cited by 118
Neuropathic and chronic pain stimuli downregulate central μ -opioid and dopaminergic transmission
Niikura, K., Narita, M., Butelman, E. R., Kreek, M. J., & Suzuki, T. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.04.003 · Cited by 106
The opioid system in depression
Jelen, L. A., Stone, J. M., Young, A. H., & Mehta, M. A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104800 · Cited by 108
O’Malley, S. S., Robin, R. W., Levenson, A. L., GreyWolf, I., Chance, L. E., Hodgkinson, C. A., Romano, D. M., Robinson, J., Meandzija, B., Stillner, V., et al. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00682.x · Cited by 102
Epigenetic Variation in the Mu-Opioid Receptor Gene in Infants with Neonatal Abstinence Syndrome
Wachman, E. M., Hayes, M. J., Lester, B. M., Terrin, N. C., Brown, M. S., Nielsen, D. A., & Davis, J. M. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.05.040 · Cited by 100
Pharmacogenetic Insights into Codeine Analgesia: Implications to Pediatric Codeine Use
Madadi, P., & Koren, G. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.9.1267 · Cited by 96
Targeting opioid dysregulation in depression for the development of novel therapeutics
Browne, C. A., & Lucki, I. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.009 · Cited by 100
Bertolino, A., Taurisano, P., Pisciotta, N., Blasi, G., Fazio, L., Romano, R., Gelao, B., Bianco, L. L., Lozupone, M., Giorgio, A. D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009348 · Cited by 98
Self-citationKim, S., Kim, C.-M., Choi, S., Jae, Y.-M., Lee, H.-G., Son, B., Kim, J., Choi, Y.-S., Kim, H.-O., Kim, S., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1330-5 · Cited by 91
Ethnicity interacts with the OPRM1 gene in experimental pain sensitivity
Hastie, B. A., Riley, J. L., Kaplan, L., Herrera, D. G., Campbell, C. M., Virtusio, K., Mogil, J. S., Wallace, M. R., & Fillingim, R. B. (2012) · Pain · doi:10.1016/j.pain.2012.03.022 · Cited by 90
Genetic Mutations that Prevent Pain: Implications for Future Pain Medication
Oertel, B. G., & Lötsch, J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.2.179 · Cited by 90
Crettol, S., Besson, J., Croquette-Krokar, M., Hämmig, R., Gothuey, I., Monnat, M., Déglon, J., Preisig, M., & Eap, C. B. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.009 · Cited by 89
Association ofOPRD1polymorphisms with heroin dependence in a large case-control series
Nelson, E. C., Lynskey, M. T., Heath, A. C., Wray, N. R., Arpana Agrawal, A., Shand, F., Henders, A. K., Wallace, L. M., Todorov, A. A., Schrage, A. J., et al. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00445.x · Cited by 87
Bruehl, S., Burns, J. W., Chung, O. Y., & Chont, M. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.12.003 · Cited by 88
Common single nucleotide variants underlying drug addiction: more than a decade of research
Bühler, K., Giné, E., Echeverry‐Alzate, V., Calleja‐Conde, J., de Fonseca, F. R., & López‐Moreno, J. A. (2015) · Addiction Biology · doi:10.1111/adb.12204 · Cited by 96
Endogenous Opioid Blockade and Impulsive Responding in Alcoholics and Healthy Controls
Mitchell, J., Tavares, V. C., Fields, H. L., D’Esposito, M., & Boettiger, C. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301226 · Cited by 89
Schacht, J. P., Anton, R. F., Voronin, K. E., Randall, P. K., Li, X., Henderson, S., & Myrick, H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.195 · Cited by 88
Patriquin, M. A., Bauer, I. E., Soares, J. C., Graham, D. P., & Nielsen, D. A. (2015) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000095 · Cited by 89
Genetics and Smoking Cessation
Lerman, C. E., Schnoll, R. A., & Munafo, M. R. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.09.006 · Cited by 88
Lim, J.-E., Papp, A. C., Pinsonneault, J. K., Sadée, W., & Saffen, D. W. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001797 · Cited by 87
Self-citation
Metadata
- Authors
- Zhang, Y., Wang, D., Johnson, A. D., Papp, A. C., & Sadée, W.
- Affiliations
- The Ohio State University (US)
- Corresponding author
- Sadée, Wolfgang
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 280
- Issue
- 38
- Pages
- 32618-32624
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1996783118
- Cited by
- 563
- References
- 44
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 9 · 2023: 11 · 2022: 27 · 2021: 14 · 2020: 21 · 2019: 24 · 2018: 24 · 2017: 26 · 2016: 22 · 2015: 41 · 2014: 39 · 2013: 37 · 2012: 46
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA018744, R21DA018744)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- mu-opioid receptor, OPRM1, A118G polymorphism, gene dosage imbalance, mRNA stability, transcriptional defects, receptor expression, human brain tissue
- MeSH terms
- Alleles, Animals, Brain, Cell Line, Dactinomycin, DNA, Gene Frequency, Genotype, Cricetinae, Heterozygote, Humans, Nucleic Acid Conformation, Plasmids, Polymorphism, Genetic, RNA, Messenger, Time Factors, Transcription, Genetic, Transfection, Genetic Variation, Blotting, Western, Mutagenesis, Mutagenesis, Site-Directed, CHO Cells, Receptors, Opioid, mu, DNA, Complementary, Nucleic Acid Synthesis Inhibitors, Substance-Related Disorders, Genetic Predisposition to Disease, Reverse Transcriptase Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Allelic Imbalance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
